Net proceeds from the offering of more than 4.9 million shares will be used for working capital and other general corporate purposes.
The offering was a follow-on to a capital raise during the summer that brought in $6 million. The company's CEO said the additional financing was needed to execute on its business plan.
The firm raised €4.7 million through a conditional placement, and €5.0 million through an unconditional direct subscription.
Earlier this month, Angle placed about 34.8 million new ordinary shares at 35 pence per share, grossing £12.2 million.
The firm, which said last week it expected to raise $15.9 million, has said it will use the net proceeds for working capital and general corporate purposes.
The company said it plans to use the net proceeds for working capital and general corporate purposes.
The offer of $402 per share was made in connection with Abbott's acquisition of Alere, which was completed on Tuesday.
The company said it plans to use the proceeds raised in the private placement primarily to fund its Hodgkin's lymphoma test clinical trial.
The company will use the net proceeds to finance its current operations and expand its US commercialization capacities for its lead product, Epi proColon.
The company said it will use the proceeds from the offering for working capital and general corporate purposes, among other things.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.
In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.
NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.